Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Receivables - Net (2016 - 2025)

Xtant Medical Holdings has reported Receivables - Net over the past 16 years, most recently at $20.0 million for Q4 2025.

  • Quarterly Receivables - Net fell 9.5% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2025, down 9.5% year-over-year, with the annual reading at $20.0 million for FY2025, 9.5% down from the prior year.
  • Receivables - Net was $20.0 million for Q4 2025 at Xtant Medical Holdings, down from $25.5 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $27.0 million in Q2 2025 and troughed at $6.3 million in Q3 2021.
  • The 5-year median for Receivables - Net is $16.4 million (2023), against an average of $15.6 million.
  • Year-over-year, Receivables - Net decreased 27.88% in 2021 and then surged 99.94% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $7.2 million in 2021, then surged by 51.71% to $10.9 million in 2022, then surged by 99.94% to $21.7 million in 2023, then increased by 1.84% to $22.1 million in 2024, then dropped by 9.5% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Receivables - Net are $20.0 million (Q4 2025), $25.5 million (Q3 2025), and $27.0 million (Q2 2025).